Lindstrom, N. O. et al. Integrated beta-catenin, BMP, PTEN, and Notch signalling patterns the nephron. eLife 3, e04000 (2015).
Lindstrom, N. O. et al. Spatial transcriptional mapping of the human nephrogenic program. Dev. Cell 56, 2381–2398.e2386 (2021).
Costantini, F. & Kopan, R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell 18, 698–712 (2010).
Rymer, C. et al. Renal blood flow and oxygenation drive nephron progenitor differentiation. Am. J. Physiol. Ren. Physiol. 307, F337–345 (2014).
Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 536, 238 (2016).
Morizane, R., Lam, A. Q., Freedman, B. S., Kishi, S., Valerius, M. T. & Bonventre, J. V. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193–1200 (2015).
Morizane, R., Monkawa, T. & Itoh, H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem. Biophys. Res. Commun. 390, 1334–1339 (2009).
Taguchi, A. et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14, 53–67 (2014).
Homan, K. A. et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat. Methods 16, 255–262 (2019).
Wu, H., Uchimura, K., Donnelly, E. L., Kirita, Y., Morris, S. A. & Humphreys, B. D. Comparative analysis and refinement of human PSC-derived kidney organoid differentiation with single-cell transcriptomics. Cell Stem Cell 23, 869–881.e868 (2018).
Sharmin, S. et al. Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation. J. Am. Soc. Nephrol. 27, 1778–1791 (2016).
Koning, M. et al. Vasculogenesis in kidney organoids upon transplantation. NPJ Regen. Med. 7, 40 (2022).
van den Berg, C. W. et al. Renal subcapsular transplantation of PSC-derived kidney organoids induces neo-vasculogenesis and significant glomerular and tubular maturation in vivo. Stem Cell Rep. 10, 751–765 (2018).
Bantounas, I. et al. Generation of functioning nephrons by implanting human pluripotent stem cell-derived kidney progenitors. Stem Cell Rep. 10, 766–779 (2018).
Dorison, A., Forbes, T. A. & Little, M. H. What can we learn from kidney organoids? Kidney Int. 102, 1013–1029 (2022).
Morizane, R. & Bonventre, J. V. Kidney organoids: a translational journey. Trends Mol. Med. 23, 246–263 (2017).
Nishinakamura, R. Human kidney organoids: progress and remaining challenges. Nat. Rev. Nephrol. 15, 613–624 (2019).
Freedman, B. S. Physiology assays in human kidney organoids. Am. J. Physiol. Ren. Physiol. 322, F625–F638 (2022).
Gubler, M. C. & Antignac, C. Renin-angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int. 77, 400–406 (2010).
Gubler, M. C. Renal tubular dysgenesis. Pediatr. Nephrol. 29, 51–59 (2014).
Gribouval, O. et al. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum. Mutat. 33, 316–326 (2012).
Gribouval, O. et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat. Genet. 37, 964–968 (2005).
Vincent, K. M. et al. Expanding the clinical spectrum of autosomal-recessive renal tubular dysgenesis: two siblings with neonatal survival and review of the literature. Mol. Genet. Genom. Med. 10, e1920 (2022).
Schreiber, R., Gubler, M. C., Gribouval, O., Shalev, H. & Landau, D. Inherited renal tubular dysgenesis may not be universally fatal. Pediatr. Nephrol. 25, 2531–2534 (2010).
Demirgan, E. B. et al. AGTR1-related renal tubular dysgeneses may not be fatal. Kidney Int. Rep. 6, 846–852 (2021).
Oberg, K. C., Pestaner, J. P., Bielamowicz, L. & Hawkins, E. P. Renal tubular dysgenesis in twin-twin transfusion syndrome. Pediatr. Dev. Pathol. 2, 25–32 (1999).
Landing, B. H., Ang, S. M., Herta, N., Larson, E. F. & Turner, M. Labeled lectin studies of renal tubular dysgenesis and renal tubular atrophy of postnatal renal ischemia and end-stage kidney disease. Pediatr. Pathol. 14, 87–99 (1994).
Mahieu-Caputo, D. et al. Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system. Am. J. Pathol. 156, 629–636 (2000).
Williams, B. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy? Min. Electrolyte Metab. 24, 400–405 (1998).
Kang, Y. S. et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J. Mol. Endocrinol. 36, 377–388 (2006).
Almeida, L. F., Tofteng, S. S., Madsen, K. & Jensen, B. L. Role of the renin-angiotensin system in kidney development and programming of adult blood pressure. Clin. Sci. 134, 641–656 (2020).
Tufro-McReddie, A., Romano, L. M., Harris, J. M., Ferder, L. & Gomez, R. A. Angiotensin II regulates nephrogenesis and renal vascular development. Am. J. Physiol. 269, F110–115 (1995).
Feliers, D. & Kasinath, B. S. Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells. Mol. Cell Endocrinol. 314, 136–142 (2010).
Simon, M. et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 268, F240–250 (1995).
Madsen, K. et al. Angiotensin II promotes development of the renal microcirculation through AT1 receptors. J. Am. Soc. Nephrol. 21, 448–459 (2010).
Ballermann, B. J. Dependence of renal microvessel density on angiotensin II: only in the fetus? J. Am. Soc. Nephrol. 21, 386–388 (2010).
Mounier, F. et al. Ontogenesis of angiotensin-I converting enzyme in human kidney. Kidney Int. 32, 684–690 (1987).
Wang, D. H., Du, Y., Zhao, H., Granger, J. P., Speth, R. C. & Dipette, D. J. Regulation of angiotensin type 1 receptor and its gene expression: role in renal growth. J. Am. Soc. Nephrol. 8, 193–198 (1997).
Zhang, S. L., Guo, J., Moini, B. & Ingelfinger, J. R. Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Kidney Int. 66, 2181–2192 (2004).
Corvol, P., Michaud, A., Gribouval, O., Gasc, J. M. & Gubler, M. C. Can we live without a functional renin-angiotensin system? Clin. Exp. Pharm. Physiol. 35, 431–433 (2008).
Shankar, A. S. et al. Human kidney organoids produce functional renin. Kidney Int. 99, 134–147 (2021).
Pupilli, C. et al. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J. Am. Soc. Nephrol. 10, 245–255 (1999).
Duvall, K., Crist, L., Perl, J. A., Pode Shaked, N., Chaturvedi, P. & Kopan, R. Revisiting the role of Notch in nephron segmentation confirms a role for proximal fate selection during mouse and human nephrogenesis. Development 149, dev200446 (2022).
Morizane, R. & Bonventre, J. V. Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells. Nat. Protoc. 12, 195–207 (2017).
Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568 (2015).
Kim, Y. K. et al. Gene-edited human kidney organoids reveal mechanisms of disease in podocyte development. Stem Cells 35, 2366–2378 (2017).
Uchimura, K., Wu, H., Yoshimura, Y. & Humphreys, B. D. Human pluripotent stem cell-derived kidney organoids with improved collecting duct maturation and injury modeling. Cell Rep. 33, 108514 (2020).
Selfa, I. L., Gallo, M., Montserrat, N. & Garreta, E. Directed differentiation of human pluripotent stem cells for the generation of high-order kidney organoids. Methods Mol. Biol. 2258, 171–192 (2021).
Cruz, N. M. & Freedman, B. S. Differentiation of human kidney organoids from pluripotent stem cells. Methods Cell Biol. 153, 133–150 (2019).
Miao, Z. et al. Single cell regulatory landscape of the mouse kidney highlights cellular differentiation programs and disease targets. Nat. Commun. 12, 2277 (2021).
Marable, S. S., Chung, E., Adam, M., Potter, S. S. & Park, J. S. Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome. JCI Insight 3, e97497 (2018).
Chen, J., Xu, H., Aronow, B. J. & Jegga, A. G. Improved human disease candidate gene prioritization using mouse phenotype. BMC Bioinforma. 8, 392 (2007).
Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305–311 (2009).
Greene, A. S. & Amaral, S. L. Microvascular angiogenesis and the renin-angiotensin system. Curr. Hypertens. Rep. 4, 56–62 (2002).
Jarmas, A. E., Brunskill, W. E., Chaturvedi, P., Salomonis, N. & Kopan, R. Progenitor translatome changes coordinated by Tsc1 increase perception of Wnt signals to end nephrogenesis. Nat. Commun. 12, 6332 (2021).
Zhuo, J. L. & Li, X. C. Proximal nephron. Compr. Physiol. 3, 1079–1123 (2013).
Low, J. H. et al. Generation of human PSC-derived kidney organoids with patterned nephron segments and a De Novo vascular network. Cell Stem Cell 25, 373–387.e379 (2019).
Marti, H. H. & Risau, W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. USA 95, 15809–15814 (1998).
Yanofsky, S. M. et al. Angiotensin II biphasically regulates cell differentiation in human iPSC-derived kidney organoids. Am. J. Physiol. Ren. Physiol. 321, F559–F571 (2021).
de Kloet, A. D., Krause, E. G., Kim, D. H., Sakai, R. R., Seeley, R. J. & Woods, S. C. The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis. Endocrinology 150, 4114–4123 (2009).
Zhao, Q., Ishibashi, M., Hiasa, K., Tan, C., Takeshita, A. & Egashira, K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 44, 264–270 (2004).
Xia, Y., Zhou, C. C., Ramin, S. M. & Kellems, R. E. Angiotensin receptors, autoimmunity, and preeclampsia. J. Immunol. 179, 3391–3395 (2007).
Ager, E. I., Neo, J. & Christophi, C. The renin-angiotensin system and malignancy. Carcinogenesis 29, 1675–1684 (2008).
Li, Y., Yan, Z., Chaudhry, K. & Kazlauskas, A. The Renin-Angiotensin-Aldosterone System (RAAS) Is One of the Effectors by Which Vascular Endothelial Growth Factor (VEGF)/Anti-VEGF Controls the Endothelial Cell Barrier. Am. J. Pathol. 190, 1971–1981 (2020).
Hilgers, K. F., Reddi, V., Krege, J. H., Smithies, O. & Gomez, R. A. Aberrant renal vascular morphology and renin expression in mutant mice lacking angiotensin-converting enzyme. Hypertension 29, 216–221 (1997).
Oliverio, M. I. et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc. Natl. Acad. Sci. USA 95, 15496–15501 (1998).
Kajiwara, K., Ozawa, K., Wada, S. & Samura, O. Molecular mechanisms underlying twin-to-twin transfusion syndrome. Cells 11, 3268 (2022).
Loquet, P., Pipkin, F.B., Symonds, E.M. & Rubin, P.C. Influence of raising maternal blood pressure with angiotensin II on utero-placental and feto-placental blood velocity indices in the human. Clin. Sci. 78, 95–100 (1990).
Nonn, O. et al. Maternal angiotensin increases placental leptin in early gestation via an alternative renin-angiotensin system pathway: suggesting a link to preeclampsia. Hypertension 77, 1723–1736 (2021).
Fischer, B. & Bavister, B. D. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J. Reprod. Fertil. 99, 673–679 (1993).
Garcia-Martinez, S. et al. Mimicking physiological O2 tension in the female reproductive tract improves assisted reproduction outcomes in pig. Mol. Hum. Reprod. 24, 260–270 (2018).
Keeley, T. P. & Mann, G. E. Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiol. Rev. 99, 161–234 (2019).
Sparrow, D. B. et al. A mechanism for gene-environment interaction in the etiology of congenital scoliosis. Cell 149, 295–306 (2012).
Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109 (2011).
Haeussler, M. et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 17, 148 (2016).
Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479–1491 (2013).
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X. & Zhang, F. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84–88 (2016).
Omer, D. et al. Human kidney spheroids and monolayers provide insights into SARS-CoV-2 renal interactions. J. Am. Soc. Nephrol. 32, 2242–2254 (2021).
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–527 (2016).
Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Watson, C. L. et al. An in vivo model of human small intestine using pluripotent stem cells. Nat. Med. 20, 1310–1314 (2014).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41467-023-43795-x